Cai Xue, Liebe Heather L, Golubkova Alena, Leiva Tyler, Hunter Catherine J
Department of Surgery, The University of Oklahoma Health Sciences Center, 800 Research Parkway Suite 449, Oklahoma City, OK 73104, Japan.
Division of Pediatric Surgery, Oklahoma Children's Hospital, Oklahoma City, OK 73104, Japan.
Curr Pediatr Rev. 2023;19(3):285-295. doi: 10.2174/1573396318666220805110947.
Necrotizing enterocolitis (NEC) is a devastating disease that primarily affects the gastrointestinal tract of premature neonates. The diagnosis and treatment of NEC remain challenging. New biomarkers and potential treatments for NEC have emerged in recent years, leading to the potential of earlier therapeutic intervention and improved outcomes. This paper aims to provide a review of the most recent diagnostic indicators and therapeutics of NEC along with a brief overview of future directions of research into this disease.
坏死性小肠结肠炎（NEC）是一种主要影响早产儿胃肠道的毁灭性疾病。NEC的诊断和治疗仍然具有挑战性。近年来出现了NEC的新生物标志物和潜在治疗方法，这使得早期治疗干预和改善预后成为可能。本文旨在综述NEC的最新诊断指标和治疗方法，并简要概述该疾病未来的研究方向。
